Troglitazone-induced fulminant hepatitis - Report of a case withautopsy findings

Authors
Li, H Heller, DS Leevy, CB Zierer, KG Klein, KM
Citation
H. Li et al., Troglitazone-induced fulminant hepatitis - Report of a case withautopsy findings, J DIABET C, 14(3), 2000, pp. 175-177
Citations number
4
Categorie Soggetti
Endocrynology, Metabolism & Nutrition
Journal title
JOURNAL OF DIABETES AND ITS COMPLICATIONS
ISSN journal
10568727 → ACNP
Volume
14
Issue
3
Year of publication
2000
Pages
175 - 177
Database
ISI
SICI code
1056-8727(200005/06)14:3<175:TFH-RO>2.0.ZU;2-Z
Abstract
Troglitazone is an insulin-sensitizing agent used to treat type 2 diabetes mellitus. Several cases have been reported of troglitazone-induced hepatic injury; some requiring transplantation, others resulting in death. We here present a case of troglitazone-induced fulminant hepatic necrosis that led to the death of the patient. (C) 2000 Elsevier Science Inc. All rights rese rved.